These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20133271)

  • 1. Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART.
    Pinnetti C; Floridia M; Cingolani A; Visconti E; Cavaliere AF; Celentano And LP; Tamburrini E
    HIV Clin Trials; 2009; 10(6):403-12. PubMed ID: 20133271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose metabolism in HIV-infected pregnant women: a retrospective analysis.
    Moore R; Adler H; Jackson V; Lawless M; Byrne M; Eogan M; Lambert JS
    Int J STD AIDS; 2016 Jun; 27(7):581-5. PubMed ID: 25999164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hcv coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy.
    Snijdewind IJ; Smit C; Godfried MH; Nellen JF; de Wolf F; Boer K; van der Ende ME
    J Infect; 2012 Apr; 64(4):409-16. PubMed ID: 22227465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational diabetes mellitus in a cohort of HIV-1 infected women.
    González-Tomé MI; Ramos Amador JT; Guillen S; Solís I; Fernández-Ibieta M; Muñoz E; Almeda J; Rojano X; Rojo P; Nieto O;
    HIV Med; 2008 Nov; 9(10):868-74. PubMed ID: 18983478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating highly active antiretroviral therapy with newer protease inhibitors is associated with better survival compared to first-generation protease inhibitors or nevirapine.
    Crane HM; Van Rompaey SE; Kitahata MM
    AIDS Patient Care STDS; 2007 Dec; 21(12):920-9. PubMed ID: 18154489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of gestational diabetes mellitus and glucose abnormalities in pregnant women with hepatitis C virus infection in British Columbia.
    Buresi MC; Lee J; Gill S; Kong JM; Money DM; Yoshida EM;
    J Obstet Gynaecol Can; 2010 Oct; 32(10):935-41. PubMed ID: 21176301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.
    Szyld EG; Warley EM; Freimanis L; Gonin R; Cahn PE; Calvet GA; Duarte G; Melo VH; Read JS;
    AIDS; 2006 Nov; 20(18):2345-53. PubMed ID: 17117021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS Clinical Trials Group A5084.
    Hitti J; Andersen J; McComsey G; Liu T; Melvin A; Smith L; Stek A; Aberg J; Hull A; Alston-Smith B; Watts DH; Livingston E;
    Am J Obstet Gynecol; 2007 Apr; 196(4):331.e1-7. PubMed ID: 17403409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational diabetes mellitus in HIV-infected pregnant women: A systematic review and meta-analysis.
    Biadgo B; Ambachew S; Abebe M; Melku M
    Diabetes Res Clin Pract; 2019 Sep; 155():107800. PubMed ID: 31362053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.
    Floridia M; Mastroiacovo P; Tamburrini E; Tibaldi C; Todros T; Crepaldi A; Sansone M; Fiscon M; Liuzzi G; Guerra B; Vimercati A; Vichi F; Vicini I; Pinnetti C; Marconi AM; Ravizza M;
    BJOG; 2013 Nov; 120(12):1466-75. PubMed ID: 23721372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of protease inhibitor therapy on glucose intolerance in pregnancy.
    Tang JH; Sheffield JS; Grimes J; McElwee B; Roberts SW; Laibl V; McIntire DD; Wendel GD
    Obstet Gynecol; 2006 May; 107(5):1115-9. PubMed ID: 16648418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
    Baroncelli S; Villani P; Floridia M; Pirillo MF; Galluzzo CM; Cusato M; Amici R; Pinnetti C; Sabbatini F; Molinari A; Tamburrini E; Regazzi M
    Ther Drug Monit; 2008 Oct; 30(5):604-10. PubMed ID: 18728627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women.
    ; Patel D; Cortina-Borja M; Thorne C; Newell ML
    Clin Infect Dis; 2007 Jun; 44(12):1647-56. PubMed ID: 17516411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?
    Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L
    Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.